Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
SNW:FRA
Sanofi SA
79,94 €
+1,50%
(+1,18) 1D
30 apr, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SNW...
Açın
78,19 €
High
80,00 €
Low
78,00 €
Mkt. cap
96,36 mlrd
Avg. vol.
1,76K
Volume
617,00
P/E ratio
12,93
52-wk high
98,40 €
52-wk low
75,06 €
EPS
6,18 €
Shares outstanding
1,25 mlrd
No. of employees
75K
News stories
From sources across the web
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in the Forbes Global 2000 was 89. Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOPaul Hudson
Employees74,8K
Founded1973
HeadquartersParis, İl de Frans, Fransa
SectorPharmaceutical industry
Websitesanofi.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
iyn 2025
sen 2025
dek 2025
mar 2026
Revenue
10,74 mlrd
13,17 mlrd
12,20 mlrd
11,24 mlrd
Cost of goods sold
2,99 mlrd
3,41 mlrd
3,63 mlrd
3,06 mlrd
Cost of revenue
2,99 mlrd
3,41 mlrd
3,63 mlrd
3,06 mlrd
Research and development expenses
1,91 mlrd
1,83 mlrd
2,29 mlrd
1,75 mlrd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,32 mlrd
2,29 mlrd
2,82 mlrd
2,33 mlrd
Operating expense
6,03 mlrd
5,97 mlrd
6,84 mlrd
5,94 mlrd
Total operating expenses
9,02 mlrd
9,39 mlrd
10,46 mlrd
9,00 mlrd
Operating income
1,71 mlrd
3,78 mlrd
1,74 mlrd
2,25 mlrd
Other non operating income
-24,00 mln
-
122,00 mln
-40,00 mln
EBT including unusual items
1,47 mlrd
3,51 mlrd
-1,16 mlrd
2,01 mlrd
EBT excluding unusual items
1,74 mlrd
3,67 mlrd
1,70 mlrd
2,14 mlrd
Income tax expense
230,00 mln
680,00 mln
-348,00 mln
420,00 mln
Effective tax rate
15,68%
19,38%
30,13%
20,85%
Other operating expenses
1,42 mlrd
1,39 mlrd
1,19 mlrd
1,33 mlrd
Net income
3,94 mlrd
2,80 mlrd
-801,00 mln
1,61 mlrd
Net profit margin
36,70%
21,28%
-6,56%
14,35%
Earnings per share
-
-
1,53
1,88
Interest and investment income
72,00 mln
114,00 mln
79,00 mln
60,00 mln
Interest expense
-62,00 mln
-227,00 mln
-
-138,00 mln
Net interest expenses
10,00 mln
-113,00 mln
79,00 mln
-78,00 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
2,48 mlrd
4,20 mlrd
3,49 mlrd
2,78 mlrd
Gain or loss from assets sale
-266,00 mln
266,00 mln
-79,00 mln
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer